Biotech

All Articles

Lilly- supported weight-loss biotech documents IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to de...

Aelis' marijuana make use of medicine fails phase 2b, steering Indivior to rethink $100M option

.Aelis Farma's hopes of getting an easy, favorable decision on a $100 thousand option settlement hav...

ProKidney halts phase 3 test not needed to have for tissue therapy authorization

.ProKidney has ceased some of a pair of period 3 trials for its tissue treatment for kidney ailment ...

Vaxcyte rises on 'impressive' 31-valent PCV win against Pfizer

.Vaxcyte unveiled what professionals referred to as "impressive" period 1/2 data for its own 31-vale...

Recursion's human brain illness test reveals scant documentation of effectiveness

.Recursion has discovered by means of a very early test of its tech-enabled method to medicine disco...

Acepodia, Pfizer click with each other for chemistry-based tissue therapy

.Phone it a scenario of great chemistry: Acepodia, a biotech based upon Nobel Prize-winning scientif...

Praxis epilepsy drug reduces seizures in phase 2 litigation

.Practice Preciseness Medicines has racked up one more midphase succeed in epilepsy this year, along...

Three officers surrender as Dyne messages combined data for DMD candidate

.After leaving a clinical grip several years back, Dyne Rehab has actually shown brand-new period 1/...

Arrowhead fires off period 3 data in rare metabolic ailment in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has shown its give ahead of a potential face-off along with Ionis, postin...

Pfizer, Valneva show lyme illness chance successful for 2nd booster

.Pfizer and Valneva might have concerning two more years to hang around before they produce the firs...